INTRODUCTION
The city of Wuhan, located at the Chinese province of Hubei, experienced in December 2019 an epidemic outbreak that was initially characterized as atypical pneumonia
(1,2). This disease originated
on Huanan Seafood Wholesale Market, a humid commercial establishment in which various live and dead animals are commercialized
(1,2). The pathogenic agent that caused the disease was identified as
a coronavirus family of viruses, which was originally denominated as 2019-nCoV
(3), and finally receiving the name of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), while the disease which is produced
by this virus is commonly known as Disease for 2019 Coronavirus (COVID-19), considered a viral zoonosis
(4,5). COVID-19 is characterized for fever, cough, dyspnea, myalgias and fatigue
(6).
Some patients also present digestive
(7), neurologic
(8) and cardiovascular
(9) problems. Almost 20% of the patients present severe complications. The most frequent
of those are the pneumonia and distress respiratory syndrome on adults/6). 80% of the cases that present complications are adults over 60 years/6).
On December 30, 2019, Dr. Li Wenliang (1986-2020) alerted a Wuhan group of colleagues about the COVID-19 outbreak, a disease that later cost him his life
(10). Chinese authorities notified the epidemic
outbreak just on December 31, 2019 and Huanan Market was closed on January 1, 2020
(1,2). On January 11, 2020, the first death in China was produced and in mid January, massive migration to celebrate
Chinese New Year (Lunar New Year)
(11) accelerated the contagion. Likewise, some cases started to be presented in Thailand, Japan and South Korea. On January 30, 2020, the World Health Organization (WHO) declared
a public health emergency of international interest
(12). Since that date, COVID-19 cases have been presented all around the world
(13), and the largest number of deaths has moved from
China to Europe and, now, to the United States. All of the above led to the WHO declaring a pandemic on March 11, 2020
(14). To date (beginning of January 2021), the COVID-19 has produced about two million deaths
and about ninety million infected. All of this has led the United Nations (UN) to declare that this disease constitutes the greatest test that humanity has faced since World War II
(15).
Since COVID-19 is a disease whose origin is related to animals, the aim of this article is to highlight the importance to be alert against these types of zoonoses, with special attention to COVID-19.
Coronaviruses characteristics
The coronaviruses (CoVs) are obligate intracellular parasites that take the control of cellular machinery of the host in order to make viral copies and then to spread
(16). The CoVs are pathogenic agents
that have threatened human beings during thousands of years
(17). They are denominated this way because of the corona (crown) form that they possess when observed at electronic microphotography
(18).
In the thirties, the first CoVs in animals were identified, and decades later other infection causes in humans were identified
(17). CoVs belong to the Nidovirales order, Coronaviridae family, Coronavirinae subfamily/19).
There exist four types of coronavirus, namely: Alfacoronavirus, Betacoronavirus, Gammacoronavirus y Deltacoronavirus
(19,20).
From a structural perspective, CoVs possess a diameter between 60 nm and 140 nm and possess projections similar to spicules on their surface
(18). CoVs also possess non segmented genomes that share a similar
organization
(17), which consists of a single stranded positive sense RNA (+ssRNA) (~ 30 knt) with 5’-cap structure and 3’-poly-A tail
(20). About two-thirds of its genome contains two large overlapping
open reading frames (ORF1a and ORF1b), which are translated into the replicase polyproteins pp1a and pp1ab
(17). Polyproteins are further processed in order to generate 16 non-structural proteins, which are designated
nsp1 ~ 16. The remaining portion of the genome contains open reading frames for structural proteins, including spike glycoprotein (S), envelope protein (E), membrane protein (M) and nucleoprotein (N)
(17). Several
lineage specific accessory proteins are also encoded according to the different existing lineages of CoVs
(17).
In the case of SARS-CoV-2, it was originally identified as a spherical virus with certain pleomorphic
(3).The virus particles possess very distinct spicules, of approximately 9 to 12 nm, granting to virions
a solar crown appearance
(3), typical of the CoVs. The phylogenetic analysis determined that this pathogenic agent is part of the Betacoronavirus genre, Sarbecovirus (2B group)
(3). Research
shows that SARS-CoV-2 RNA sequence consists of 29 870 nucleotides of longitude (about 9744 amino acids)
(21). Its genetic sequence is almost identical to that of SARS-CoV (which caused the Severe Acute Respiratory
Syndrome epidemic in 2003), sharing 79.6% of the sequence identity with it
(22).
SARS-CoV-2 is able to infect pneumocytes type 2 and ciliated bronchial epithelial cells in human beings
(4), which show the angiotensin-converting enzyme protein (ACE2). It is reported that SARS-CoV-2 enters
to these respiratory system cells thanks to a receptor-binding domain that is located in the spike glycoprotein (S)
(23), a domain that is recognized and binds to the peptidase domain extracellular ACE2 mainly
through polar residues
(23). It is known that ACE2 is expressed at digestive epithelium level
(7) and brain tissues (being specifically detected on glial and neuronal cells)
(8).
This is why these tissues constitute a potential objective for SARS-CoV-2.
COVID-19 as a zoonosis
A zoonosis is an infectious disease in which causal pathogenic agents possess, in general, a wild animal reservoir
(24), and from this animal reservoir, which is generally asymptomatic, the pathogen can
be directly transmitted to human beings or domestic animals, who in turn can transmit it to human beings
(24). It is demonstrated that the seven human CoVs have a zoonotic origin, and depending on the virus, exists
different reservoirs and intermediaries
(17). Regarding the above, a great amount of research has previously warned of the big zoonotic potential and permanent epidemic risk that is constituted in CoVs that are
present in some species of bats
(25-27).
SARS-CoV-2 is considered as zoonotic
(4,13,28,29). It is known that this coronavirus is 96% identical in complete genome level in comparison to a horseshoe
bat coronavirus (Rhinolophus affinis), who lives in some regions of China and that has been proposed as its reservoir
(22,30) (Figure 1). With respect to the intermediary host, there exists a lot
of interest in identifying it
(30). It has been found that Malayan pangolins (Manis javanica) possess a coronavirus whose genome has between 85.5% to 92.4% of sequence similarity with SARS-CoV-2, which has led
to propose that it may be the intermediary
(31).
Recent investigation proposes the possibility that ferrets and cats may get infected with SARS-CoV-2 and transmit it again to human beings
(32,33), continuing with a zoonotic cycle with
the greatest difficulty to control the spread of COVID-19 in these animals
(33). The above mentioned must be taken into account, especially with respect to common pets as cats. However, more research is required
in order to determine effectively this possibility of contagion.
The importance of of Unique Health approach against zoonoses
Health should be seen as a holistic integrator concept. The approach Unique Health (or One Health) arose some years ago as a holistic approximation to the Health concept, an approach in which some aspects which were originally
separated are collaboratively associated, or even in different spheres; human health, animal health and environmental health
(34). The Unique Health approach, from its updated, integrative, multidisciplinary and
multifactorial perspective, is very useful when it comes to comprehend both the transmission and prevention of zoonotic pathogenic agents, emerging or reemerging
(34), as SARS-CoV-2 and related coronaviruses.
The Unique Health approach is capable of implementing in a better way, and with updated knowledge, the permanent prevention measures and oportune response that is required by localized epidemic outbreaks that may become into a pandemic
(13),
as it has happened with COVID-19 and it may happen to other epidemics with a zoonotic origin in the future. It is necessary for the Unique Health approach to be known by physicians and other health professionals
(29,35,36),
as veterinarians, biologists, biochemists, biotechnologists, pharmaceutical chemists, zootechnician engineers, food engineers, environmental professionals, psychologists as well as health educators, among many others
(4).
In order to ensure an updated training about this topic between professionals that work in health, universities should integrate in their curricular innovations the concept Unique Health as soon as possible, in the contents that tribute
to the graduation profile of those professions
(35,37).
Conclusions and future projections
Nowadays, various public and private organizations are participating in a real race in order to develop effectives vaccines against SARS-CoV-2 as well as drugs which help on COVID-19 treatment
(38). It
is important that the international biomedical community recognizes that COVID-19 is a zoonosis, and an unequivocal determination of which are the species that are its natural reservoir and its intermediary is extremely important, both
to obtain future vaccine and to develop drugs to this disease. In that sense, the intermediary determination is useful in order to know in greater detail how the coronaviruses behave in the hosts and how do they transmit, since, in the
future, we are not excent to produce a pandemic outbreak of zoonotic pathogenic agents with similar characteristics
(26,30).
In consideration of all the above mentioned in this article it is concluded that is important for the Unique Health approach to be known, diffused and integrated for every health center and sanitary professionals, since given the
seriousness of the zoonoses as COVID-19, we should not forget that human health is linked with animal health, and these two with environmental health..
Recently, certain risk groups have been immunized with vaccines; however, they will be available to the general population in several months.. Before these projections, health organisms, both public and private, as well as the
educational institutions should put strict emphasis on the measures that prevent future contagion
(5,13). Meanwhile, in order to prevent the accelerated propagation of coronavirus, it is important
to maintain effective hygienic and preventive personal distancing measures
(38).
|
Figure 1. SARS-CoV-2 coronavirus is a zoonotic agent that has been transmitted from animals to humans. Figure created with computer program BioRender.com
Author contributions: All authors have participated in the idea conception, data collection and interpretation and writing of the article in this investigation work.
Financing: The work that originated this article did not receive financing of any project or public or private agency
Conflict of interest: The author declares that he has no conflicts of interest.
Received: May 5, 2020
Approved: December 18, 2020
Correspondence: Dr. Manuel E. Cortés
Address: Avda. Viel # 1497, Santiago, Región Metropolitana, Chile. C. P. 8370993.
Mobile: +56 2 24772244.
Email: cortesmanuel@docente.ubo.cl
REFERENCES
5. Rodriguez-Morales AJ, Sánchez-Duque JA, Hernández Botero S, Pérez-Díaz CE, Villamil-Gómez WE, Méndez CA, et al. Preparación y control de la enfermedad por coronavirus 2019 (COVID-19) en América Latina. Acta Médica
Peru. 2020; 37(1): 3-7. DOI:
https://doi.org/10.35663/amp.2020.371.909
8. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci 2020; 11(7): 995-8. DOI:
https://doi.org/10.1021/acschemneuro.0c00122
19. Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen K-Y. Coronaviruses — drug discovery and therapeutic options. Nat Rev Drug Discov. 2016; 15(5): 327-47. DOI:
https://doi.org/10.1038/nrd.2015.37
20. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020; 92(4): 418-23. DOI:
https://doi.org/10.1002/jmv.25681
21. Wang C, Liu Z, Chen Z, Huang X, Xu M, He T, et al. The establishment of reference sequence for SARS‐CoV‐2 and variation analysis. J Med Virol. 2020; 92(6): 667-74. DOI:
https://doi.org/10.1002/jmv.25762
22. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3. DOI:
http://dx.doi.org/10.1038/s41586-020-2012-7
23. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020; 367(6485): 1444-8. DOI:
https://doi.org/10.1126/science.abb2762
25. Menachery VD, Yount BL, Sims AC, Debbink K, Agnihothram SS, Gralinski LE, et al. SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci. 2016; 113(11): 3048-53. DOI:
https://doi.org/10.1073/pnas.1517719113
26. Menachery VD, Yount BL, Debbink K, Agnihothram S, Gralinski LE, Plante JA, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med 2015; 21(12): 1508-13. DOI:
https://doi.org/10.1038/nm.3985
27. Cheng VCC, Lau SKP, Woo PCY, Yuen KY. Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection. Clin Microbiol Rev 2007; 20(4): 660-94. DOI:
https://dx.doi.org/10.1128%2FCMR.00023-07
32. Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science 2020; eabb7015. DOI:
https://doi.org/10.1126/science.abb7015
34. El Zowalaty ME, Järhult JD. From SARS to COVID-19: A previously unknown SARS-CoV-2 virus of pandemic potential infecting humans –Call for a One Health approach. One Heal 2020; 100124. DOI:
https://doi.org/10.1016/j.onehlt.2020.100124
36. Lorusso A, Calistri P, Mercante MT, Monaco F, Portanti O, Marcacci M, et al. A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Heal 2020; 100135. DOI:
https://dx.doi.org/10.1016%2Fj.onehlt.2020.100135
37. Cortés ME. Enfermedad por coronavirus: la importancia de enseñar zoonosis bajo el enfoque de «Una sola salud». Investig Educ Médica. 2020;35: accepted, in press.